THIS NOVEL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain malignancy known for its fast growth and insensitivity to typical treatments. Investigations are constantly underway to identify new treatment strategies, and recently, a new biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is abundantly produced in gli